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ABSTRACT
• Background: Early intervention in psychosis is an opportunity. Research ahs shown that if any thing 
community members can do to prevent psychosis is to report early. This has opened newer vistas for 
understanding the complexity of brain and behaviour in schizophrenia. At the same time it has raised the 
bar of expectations regarding its correlation to outcome. It finally narrows down to meaningful public 
campaign for awareness, which will decide success of research to clinics in schizophrenia management. 
Duration of untreated psychosis (DUP) has emerged as a reliable predictor of outcome and provides 
credence to development of early intervention services. It is not quite clear if DUP works in isolation and 
what other factors along with DUP would determine outcome long-term outcome of schizophrenia is 
multifactorial in nature. The present study examines effect of DUP on outcome of schizophrenia
• Method: we conducted a ten years follow up study of first episode hospitalized DSM III-R schizophrenia 
and correlated multiple outcome criteria with DUP at Mumbai. We carefully determined onset of 
psychosis using criteria for appearance of positive symptoms, negative symptoms or significant social 
decline. Data was analyzed using SAS.
• Results: we analyzed 101 patients available at ten years. We found that mean DUP was higher for group, 
which showed Clinical recovery on GCIS [14.0(SD=8.0) months for recovered & 10.8 (SD=5.7) months in 
nonrecovered group p=0.091]. There is a significant difference in favour of DUP≤6 months in terms of 
subscales of PANSS; However DUP was not found to be significantly associated with the end point 
parameters of good clinical or social outcome.
• Conclusion: We find that DUP is just one factor in determinants of outcome. Several other 
psychopathological & phenomenological factors collectively play a role in determining outcome. Future 
research needs to be directed towards combination of determinants of outcome in early intervention of 
psychosis
Introduction
•
• There has been intense interest in DUP because of the proposal that psychosis is some 
how neurologically toxic 1. If this is true then delay in treating people with psychosis could 
impair prognosis, while reducing delay could improve it 7. However despite the blossoming 
of early intervention services, there is continuing disagreement over whether there is a real 
association between DUP and outcome. Several conflicting evidence have been reported 
2,3,4 . 
• Though DUP has been reported as an independent marker of outcome, measurement 
errors and variability in DUP in terms of heterogeneity have also been reported and caution 
advised 5,6,. The strength of association between DUP and outcome has been found to be 
only ‘moderately strong’ based upon the available data, accounting for approximately 13% 
of variance or 1 in 3 to 1 in 4 of those who did not achieve remission 7.   Until now, very few 
long-term studies have examined this association. Long-term outcome of schizophrenia is 
multifactorial in nature. It not clearly known if short DUP is a strong determinant of long-
term outcome. 8.  The present study examines effects of DUP on clinical and social 
outcome in ten year’s long-term follow up in a cohort of first episode psychosis.
Methods
• Design
• This study is a naturalistic, prospective, longitudinal follow-up study conducted at Mumbai, India. 
Assessments were conducted at the baseline and at the end of ten years follow up by trained and 
experienced clinical research staff.    Inter-rater reliability was established for quantification of outcome.
• Sample and settings
• Two hundred patients admitted with first episode psychosis were recruited as per inclusion criteria, and 
101 were available at the end point. Wherever necessary patients were traced, contacted and assessed.   
• Inclusion criteria: 
• At base 
• Hospitalized  
• Availability of key relatives; 
• Confirmed diagnosis of psychotic disorder- non-affective as per DSM-III-R; 
• Age range of 18-45 years 
• Informed consent for participation in the study.
• At end point
• Reconfirmed diagnosis of schizophrenia as per DSM IV –TR 9 at the follow up of ten tears; 
• Informed consent 
• Available objective data from key relative
Criteria 
• Exclusion criteria: we excluded cases of primary organic 
psychotic disorder intellectual disability, drug and substance 
induced psychosis, any change in diagnosis from baseline to 
endpoint and epilepsy. comorbid alcoholism and substance 
abuse.
• The study was carried out in a non-governmental, psychiatric 
hospital certified as a psychiatric facility by the State 
Government as per Indian Mental Health Act 1983 from a 
period of 1993 to 2007. Independent Ethics Commission, 
Mumbai, approved the study. 
• Informed consent: All patients and their relatives were 
explained the nature and purpose of study and an informed 
consent was obtained at the beginning of the study as well as 
at the end of the follow up for repeat assessment.
•
Assessment of DUP
• The assessment of duration of untreated psychosis was done 
clinically by a detailed interview with the patient and the key 
relatives.  .  We carefully assessed known prodromal signs and 
tried to elicit the time of first-distressing symptoms either 
positive or negative symptom to decode the onset of illness
• Positive symptoms (hallucinations, delusions, and odd beliefs 
thought disorder)
• Negative symptoms (depression, dysphoria, apathy, anergia, 
apathy, and amotivation)   
• Social decline (withdrawn behavior, poor interpersonal 
relationship, social avoidance, and lack of interest in 
education or work) 
• Assessment tools
• We used Clinical and social outcome criteria based upon Meltzer’s 
outcome 10 criteria recommendations. We operational zed the 
definition on a scale of 1-to-5 where one represented poorest and 5 
the best outcome for some of the parameters. This scale was 
developed for the local conditions  and used in other studies 11 
Clinical Outcome was measured by 1] Clinical Global impression 
scale (CGIS) 12 2] Psychopathology (positive symptoms, negative 
symptoms and disorganization) using Positive and Negative 
syndrome scale [PANSS]) 13 l., 1987), 3] Depressive symptoms 
using Hamilton Depression Rating Scale (HDRS) 14, 4] Factors of 
Compliance, 5] EPS, using Abnormal Involuntary Movement 
Scale(AIMS) 15 6] Aggression, 7] Hospitalization, and 8] Suicidality. 
Social outcome was measured using 1] Quality of life 16, 2] Global 
Functioning using GAF,   17. 18 3] Independent living, 4] Family 
burden, and 5] Social burden measured operationalized criteria. 
Raters in this study were not blinded. 
Outcome criteria 
• We used GCIS for measuring severity as well as improvement 
by CGIS-S & CGIS-I respectively. Primary criteria - a score of 
2 or less i.e. scoring ‘improved and much improved’ rating 
were considered ‘good outcome’ on CGIS  
• Secondary outcome criteria: clinical improvement as defined 
by    
• Being not hospitalized for minimum 2 preceding years,  
• GAF >80,  
• QOL >80, 
• >3 on scales of social functions, independent living, 
education, and social burden. 
• The statistical analysis was performed using SAS, version 9.1.  
Probability values less than 0.05 were considered to be 
statistically significant.
RESULTS
• Mean duration of untreated psychosis was observed as 12.7 months 
(SD =7.3).   The majority of patients (73%) had duration of 
untreated psychosis ranging between 6 months to 24 months (Table 
1). 
• There were no differences between short and long   DUP in terms of 
age at intake and gender (Table 2, p=. 148 and p=. 799, 
respectively). 
• No statistically significant differences were observed between the 
two groups on parameters of clinical and social recovery 



Discussion
• There is a well-established association between DUP, critical period and 
early intervention. This association is independent of confounding factors, 
including premorbid functioning, gender, diagnosis and age of onset of 
symptoms variance in functional recovery has been reported 19.  
• The finding of 48 weeks DUP in the present study is not surprising from a 
developing country where stigma is rampant, awareness is poor, 
accessibility of care is limited and resources for mental health are less than 
sufficient. A DUP as much as 796 weeks has been reported from India 
which is primarily because of lack of availability and accessibility of mental 
health services rather than the psychosis remaining ‘unidentified’ 20,21. 
• Mental illness remains untreated despite recognition. There are several 
cultural, social, religious, economic and personal factors which determine 
approach to mental health care which obliviously leads to longer DUP. 22. 
Long DUP has also been reported in western literature e.g. a Canadian 
study observed duration of untreated psychosis as 84 weeks 23. 
• In the present study in a multivariate analysis, results did not 
show any statistically significant correlation between various 
categories of duration of untreated psychosis and outcome 
parameters. 
• The significant findings were the lack of correlation with 
symptom remission and level of social functions measured by 
several psychosocial parameters. 
• We compared patients with less than 12 months of DUP and 
more than 12 months of DUP and found that no clinical or 
social parameters at ten years outcome correlated DUP below 
12 months or more than 12 months.  
• This lack of association   may arise from the followings 
possibilities:
Complexity in assessment of DUP. 
• Nature of treatment being inadequate because of limited resources
• The long-term outcome in schizophrenia is not influenced by DUP 
because most of neuronal changes takes place early in the course or 
even preceding the onset and therefore an intervention as late as 12 
months does not contribute to long term outcome24  
• DUP   remains relevant only for short period of follow up and once 
the psychosis has persisted long enough,  enough toxic damage has 
been caused to change any thing in the outcome.
• The finding also indicates that longer the DUP worse the outcome 
but a shorter DUP does not necessarily mean a good outcome.
• Further, in our study out of 13 outcome parameters of clinical and 
social relevance none of the parameter showed any correlation. All 
the parameters most importantly, social function, global function, 
quality of life and independent living show no correlation. 
•
• It is likely that DUP correlates with outcome measures in 
conjunction with several other factors. It further suggests that the 
benefit of early intervention in long term is gradually lost, no matter 
when the intervention is done due to several factors such as, poor 
treatment, lack of follow up, inconsistencies in management, poor 
adherence, poor psychosocial intervention & frequent relapses.  The 
assumption that delay in treating people with psychosis could 
impair psychosis while reducing delay would improve it, is not as 
straight forward as often stated. 25 There has been continuing 
disagreement over whether there is a real association between DUP 
and outcome.    3, 26
• We need more studies comparing ultra short DUP, short DUP and 
long DUP to understand more clearly about its association with 
outcome. Further studies also need to examine how powerful 
predictor DUP is? 27.  
• Success of this concept depends upon public campaign and 
resources for treatments. Research of DUP has given a new 
responsibility for community awareness programs for early 
identification, which remains a daunting, task everywhere 28, 29 .  
SUMMARY AND CONCLUSIONS
• Our study finds that DUP alone does not determine long term 
outcome status in first episode schizophrenia. Long DUP leads to 
poor outcome and the short DUP does not necessarily lead to good 
outcome due to psychopathological heterogeneity   in early phase.  
30,31,32 ... There is a missing link in association of DUP and outcome.  
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